Lapatinib Completed Phase 1 Trials for HER2 Positive / Metastatic Brain Tumors / Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00614978Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
NCT02073916T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer